CINF vs TERN · P/E 16, rev $11.34B vs $6.12B cap
Cincinnati Financial Corporation (CINF) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CINF and TERN stock pages for the full models.
Not investment advice.